Market Research Logo

AstraZeneca PLC

AstraZeneca PLC - Strategy and SWOT Report,

- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on AstraZeneca PLC required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting AstraZeneca PLC in the form of a SWOT analysis
  • An in-depth view of the business model of AstraZeneca PLC including a breakdown and examination of key business segments
  • Intelligence on AstraZeneca PLC’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about AstraZeneca PLC, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

AstraZeneca (or 'the company'), a UK-based global biopharmaceutical company, is engaged in developing, manufacturing and marketing prescription pharmaceuticals in several therapeutic areas. The company primarily operates in the Americas, Europe and Asia. It is headquartered in London, the UK, and employed about 57,500 people as on December 31, 2014.Reasons to Purchase:

  • Gain understanding of AstraZeneca PLC and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess AstraZeneca PLC as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on AstraZeneca PLC’s business structure, strategy and prospects

  • Company Snapshot
    AstraZeneca PLC: Company Overview
    AstraZeneca PLC: Overview and Key Facts
    AstraZeneca PLC: Overview
    AstraZeneca PLC: Key Facts
    AstraZeneca PLC: Key Employees
    AstraZeneca PLC: Key Employee Biographies
    AstraZeneca PLC: Major Products and Services
    AstraZeneca PLC: Company History
    AstraZeneca PLC: Management Statement
    AstraZeneca PLC: Locations and Subsidiaries
    AstraZeneca PLC: Key Competitors
    AstraZeneca PLC: Company Analysis
    AstraZeneca PLC: Business Description
    AstraZeneca PLC: SWOT Analysis
    AstraZeneca PLC: SWOT Overview
    AstraZeneca PLC: Strengths
    AstraZeneca PLC: Weaknesses
    AstraZeneca PLC: Opportunities
    AstraZeneca PLC: Threats
    AstraZeneca PLC: Corporate Financial Deals Activity
    AstraZeneca PLC: Financial Deals Overview
    AstraZeneca PLC: Targets and Partners
    AstraZeneca PLC: Top Deals 2011 - 2015YTD*
    AstraZeneca PLC: Advisors
    AstraZeneca PLC: Top Legal Advisors
    AstraZeneca PLC: Top Financial Advisors
    AstraZeneca PLC: Mergers and Acquisitions
    AstraZeneca PLC: Corporate Venturing
    AstraZeneca PLC: Partnership
    AstraZeneca PLC: Divestments
    AstraZeneca PLC: Private Equity and Ownership
    AstraZeneca PLC: Recent Developments
    AstraZeneca PLC: News and Events Summary
    AstraZeneca PLC: Contracts
    AstraZeneca PLC: Financial Deals
    AstraZeneca PLC: Financial Performance
    AstraZeneca PLC: Regulatory and Legal Events
    AstraZeneca PLC: Research & Development
    Appendix
    Contact Us
    Methodology
    Definitions
    About Market Line
    List of Tables
    Table 1: AstraZeneca PLC: Key Facts
    Table 2: AstraZeneca PLC: Key Employees
    Table 4: AstraZeneca PLC: Key Competitors
    Table 5: AstraZeneca PLC: Deal Activity by Deal Type - Volume (TTM*)
    Table 6: AstraZeneca PLC: M&A Activity by Geography (TTM*)
    Table 7: AstraZeneca PLC: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Table 8: AstraZeneca PLC: M&A Average Deal Size - Value (US$m)
    Table 9: AstraZeneca PLC: Targets and Partners
    Table 10: AstraZeneca PLC: Top Deals 2011 - 2015YTD*
    Table 11: AstraZeneca PLC: Legal Advisor Ranking by Value (US$m)
    Table 12: AstraZeneca PLC: Financial Advisor Ranking by Value (US$m)
    Table 13: AstraZeneca PLC: M&A Volume and Value Trend (2011 - YTD*2015)
    Table 14: AstraZeneca PLC: M&A Activity by Geography (2011 - YTD*2015)
    Table 15: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2011 - YTD*2015)
    Table 16: AstraZeneca PLC: Corporate Venturing by Geography (2011 - YTD*2015)
    Table 17: AstraZeneca PLC: Partnership Volume and Value Trend (2011 - YTD*2015)
    Table 18: AstraZeneca PLC: Partnership Trend by Deal Type (2011 - YTD*2015)
    Table 19: AstraZeneca PLC: Divestments Volume and Value Trend (2011 - YTD*2015)
    Table 20: AstraZeneca PLC: Divestments by Geography (2011 - YTD*2015)
    Table 21: AstraZeneca PLC: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
    Table 22: AstraZeneca PLC: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)
    Table 23: AstraZeneca PLC: News and Events Summary
    Table 24: AstraZeneca PLC: Contracts
    Table 25: AstraZeneca PLC: Financial Deals
    Table 26: AstraZeneca PLC: Financial Performance
    Table 27: AstraZeneca PLC: Regulatory and Legal Events
    Table 28: AstraZeneca PLC: Research & Development
    List of Figures
    Figure 1: AstraZeneca PLC: Deal Activity by Deal Type - Volume (TTM*)
    Figure 2: AstraZeneca PLC: M&A Activity by Geography (TTM*)
    Figure 3: AstraZeneca PLC: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Figure 4: AstraZeneca PLC: M&A Average Deal Size - Value (US$m)
    Figure 5: AstraZeneca PLC: M&A Volume and Value Trend (2011 - YTD*2015)
    Figure 6: AstraZeneca PLC: M&A Activity by Geography (2011 - YTD*2015)
    Figure 7: AstraZeneca PLC: Corporate Venturing Volume and Value Trend (2011 - YTD*2015)
    Figure 8: AstraZeneca PLC: Corporate Venturing by Geography (2011 - YTD*2015)
    Figure 9: AstraZeneca PLC: Partnership Volume and Value Trend (2011 - YTD*2015)
    Figure 10: AstraZeneca PLC: Partnership Trend by Deal Type (2011 - YTD*2015)
    Figure 11: AstraZeneca PLC: Divestments Volume and Value Trend (2011 - YTD*2015)
    Figure 12: AstraZeneca PLC: Divestments by Geography (2011 - YTD*2015)
    Figure 13: AstraZeneca PLC: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
    Figure 14: AstraZeneca PLC: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report